AF award recipients include renowned investigator and professor emeritus
Experts Tackle Tough Pain Challenges
NIH conference brings together experts to discuss pain treatment
The DMOAD Dream a Generation Later
Few effective treatments for OA have been developed, and the approach to clinical trials might need modifications
Genome-Wide Association Studies of SLE
What do these studies tell us about disease mechanisms in lupus?
Expression of CD154 Protein Linked to Increased Risk for Developing RA
An ongoing study of key immune system proteins has pinpointed an area associated with increased risk for inflammatory disease and may one day lead to new therapies to control inflammation and rheumatic diseases.
New Approaches to Inflammatory Myopathy
Advances in diagnostic modalities and treatments emerge
Family, Fatigue & Heart Health
Researchers explore several factors in the health and well-being of patients with lupus
Chronotherapy with Glucorticoids in Rheumatoid Arthritis
Time is of the essence in balancing risks and benefits
New ACR and ARHP Leaders Join the Ranks
The ACR is pleased to welcome new and returning leaders to the ACR board of directors and ARHP executive committee who were appointed in November. The following members were selected to serve as the newest members-at-large of the ACR board of directors. Each of them shared what they will bring to the table.
A Review of Wegener’s Treatment Data
Clinical trials show changing role of existing treatment and introduction of newer medications
- « Previous Page
- 1
- …
- 62
- 63
- 64
- 65
- 66
- …
- 77
- Next Page »